manufactures

• 

  NightFood Signs Letter of Intent to Acquire Fortune 500 Licensee

  5:35 PM | November 2, 2016

  TARRYTOWN, NY — (Marketwired) — 11/02/16 — NightFood Holdings, Inc. (OTC PINK: NGTF), a fully reporting “better-for-you” snack company, today announced that it has signed a letter of intent and agreed to terms to acquire a Fortune 500 company’s licensee. The company to be acquired has secured a third-party license to manufacture and distribute their line of “better-for-you” products in an extremely popular snack category under an iconic brand name. Approval for this acquisition has already been granted by the

  Read more
• 

  EPIC The Dividend Company Is Negotiating With an Independent Party to Develop Both an International and USA Public Trading Holding Company

  2:44 PM | March 14, 2016

  EPIC Declares Quarterly Dividend and Establishes Exchange Offer That Benefits Prior Existing Shareholders AUSTIN, TX— EPOR, (Marketwired – March 13, 2016) – EPIC Corporation (OTC PINK: EPOR) and Ronald Tucker its CEO announced: “Donald Baillargeon (MoneyTV) states that EPIC as a small listed company sounds more like a large NYSE company. Click to see Interview. “EPIC The Dividend Company is an “Outside-The-Box” private public trading company and a significantly undervalued common stock. The Company provides shareholders with a high quarterly

  Read more
• Midlands Minerals Corporation and Alder Resources Ltd. announce business combination

  9:01 PM | May 28, 2015

  TORONTO, May 28, 2015 /CNW/ – Midlands Minerals Corporation (MEX: TSX-V) (“Midlands“) and Alder Resources Ltd. (ALR: TSX-V) (“Alder“) are pleased to announce that they have entered into a definitive agreement (the “Agreement“), whereby Midlands will acquire all of the outstanding shares of Alder pursuant to a statutory plan of arrangement under the Business Corporations Act(Ontario) (the “Arrangement“).  The Arrangement provides that Midlands will be acquiring each outstanding Alder common share in exchange for 1.81 common shares of Midlands (on a pre-consolidation basis).  Based on the 45

  Read more

• SBFM Secures Funding for Its Adva-27a Anticancer Compound From Dutchess Opportunity Fund II

  1:02 PM | April 29, 2014

    MONTREAL, QC, Apr 29, 2014 (Marketwired via COMTEX) — Sunshine Biopharma, Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer today announced that it has entered into an Investment Agreement with Dutchess Opportunity Fund, II, LP (“Dutchess”). Dutchess has agreed to purchase up to $2.5 million of shares of Sunshine’s Common Stock over a three-year commitment period. Under the terms of the Investment Agreement Sunshine

  Read more